111 related articles for article (PubMed ID: 15043997)
1. Characterization of the human STAT5A and STAT5B promoters: evidence of a positive and negative mechanism of transcriptional regulation.
Crispi S; Sanzari E; Monfregola J; De Felice N; Fimiani G; Ambrosio R; D'Urso M; Ursini MV
FEBS Lett; 2004 Mar; 562(1-3):27-34. PubMed ID: 15043997
[TBL] [Abstract][Full Text] [Related]
2. Differential function of STAT5 isoforms in head and neck cancer growth control.
Leong PL; Xi S; Drenning SD; Dyer KF; Wentzel AL; Lerner EC; Smithgall TE; Grandis JR
Oncogene; 2002 Apr; 21(18):2846-53. PubMed ID: 11973644
[TBL] [Abstract][Full Text] [Related]
3. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
[TBL] [Abstract][Full Text] [Related]
4. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
Wischnewski F; Friese O; Pantel K; Schwarzenbach H
Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
[TBL] [Abstract][Full Text] [Related]
5. Duplication of Stat5-binding sites within the beta-lactoglobulin promoter compromises transcription in vivo.
Pena RN; Whitelaw CB
Biochimie; 2005 Jun; 87(6):523-8. PubMed ID: 15935277
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the infection-responsive bovine lactoferrin promoter.
Zheng J; Ather JL; Sonstegard TS; Kerr DE
Gene; 2005 Jun; 353(1):107-17. PubMed ID: 15935571
[TBL] [Abstract][Full Text] [Related]
7. Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells.
Yamashita H; Iwase H; Toyama T; Fujii Y
Oncogene; 2003 Mar; 22(11):1638-52. PubMed ID: 12642867
[TBL] [Abstract][Full Text] [Related]
8. The DNA-binding capacity of genetic variants of the bovine STAT5A transcription factor.
Flisikowski K; Szymanowska M; Zwierzchowski L
Cell Mol Biol Lett; 2003; 8(3):831-40. PubMed ID: 12949622
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
Shipley JM; Waxman DJ
Toxicol Appl Pharmacol; 2004 Sep; 199(3):275-84. PubMed ID: 15364543
[TBL] [Abstract][Full Text] [Related]
10. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters.
Gustavson MD; Crawford HC; Fingleton B; Matrisian LM
Mol Carcinog; 2004 Nov; 41(3):125-39. PubMed ID: 15457508
[TBL] [Abstract][Full Text] [Related]
11. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
Grasberger H; Ye H; Mashima H; Bell GI
Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
13. The structure of human STAT5A and B genes reveals two regions of nearly identical sequence and an alternative tissue specific STAT5B promoter.
Ambrosio R; Fimiani G; Monfregola J; Sanzari E; De Felice N; Salerno MC; Pignata C; D'Urso M; Ursini MV
Gene; 2002 Feb; 285(1-2):311-8. PubMed ID: 12039059
[TBL] [Abstract][Full Text] [Related]
14. Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase.
Zelko IN; Folz RJ
Free Radic Biol Med; 2004 Oct; 37(8):1256-71. PubMed ID: 15451065
[TBL] [Abstract][Full Text] [Related]
15. A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B.
Verdier F; Rabionet R; Gouilleux F; Beisenherz-Huss C; Varlet P; Muller O; Mayeux P; Lacombe C; Gisselbrecht S; Chretien S
Mol Cell Biol; 1998 Oct; 18(10):5852-60. PubMed ID: 9742102
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activation of Stat5b contributes to carcinogenesis in vivo.
Xi S; Zhang Q; Gooding WE; Smithgall TE; Grandis JR
Cancer Res; 2003 Oct; 63(20):6763-71. PubMed ID: 14583472
[TBL] [Abstract][Full Text] [Related]
17. Effect of erythropoietin on Leydig cell is associated with the activation of Stat5 pathway.
Yamazaki T; Kanzaki M; Kamidono S; Fujisawa M
Mol Cell Endocrinol; 2004 Jan; 213(2):193-8. PubMed ID: 15062567
[TBL] [Abstract][Full Text] [Related]
18. Sp1 and AP2 enhance promoter activity of the mouse GM3-synthase gene.
Xia T; Zeng G; Gao L; Yu RK
Gene; 2005 May; 351():109-18. PubMed ID: 15890474
[TBL] [Abstract][Full Text] [Related]
19. Coactivators in gene regulation by STAT5.
Litterst CM; Kliem S; Lodrini M; Pfitzner E
Vitam Horm; 2005; 70():359-86. PubMed ID: 15727811
[TBL] [Abstract][Full Text] [Related]
20. ERalpha and STAT5a cross-talk: interaction through C-terminal portions of the proteins decreases STAT5a phosphorylation, nuclear translocation and DNA-binding.
Wang Y; Cheng CH
FEBS Lett; 2004 Aug; 572(1-3):238-44. PubMed ID: 15304355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
